Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the ...

Kura Oncology and Kyowa Kirin reported positive Phase 2 results for ziftomenib in AML and plan Phase 3 trials, with an NDA ...

H.C. Wainwright maintained a Buy rating on Kura Oncology (NASDAQ:KURA) and raised the price target to $40.00 from the previous $37.00. Trading at $9.05, the stock has seen a strong 12.7% gain over the ...

BTIG analyst Justin Zelin downgraded Kura Oncology stock (NASDAQ:KURA) from Buy to Neutral. Zelin cited concerns over the recent KOMET-001 study results for the company's drug, ziftomenib. The ...

Kuro Oncology and partner Kyowa Kirin are on track for an NDA submission for ziftomenib in the second quarter of this year.

H.C. Wainwright raised the firm’s price target on Kura Oncology (KURA) to $40 from $37 and keeps a Buy rating on the shares. The firm says the ...

The U.K. is continuing to shape up regulation, adding reform of its accelerated drug approval process and its draft guidance on personalized mRNA cancer vaccines to new clinical trial regulations that ...

Kura Oncology (KURA) and Kyowa Kirin announced topline results from KOMET-001, the Phase 2 registration-directed trial of ziftomenib, a highly ...

Former Winnipeg Jets, Washington Capitals and New Jersey Devils coach Tom McVie has died. He was 89. McVie also coached the ...

The eponymous designer of the P.13a, aircraft engineer Alexander Martin Lippisch (November 2, 1894-February 11, 1976), had already cemented his place in aviation history by designing the Luftwaffe ...